APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioids Drug

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Selected research

Market Structure

Global Opioids Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchOpioids Drug Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioids Drug Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Opioids Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioids Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioids Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.

This report provides an overview of the global Opioids Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Opioids Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Opioids Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Opioids Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Opioids Drug Segment by Company

Teva

Purdue Pharma

Mallinckrodt

Amneal Pharma

Collegium

J&J

Endo

Pfizer

INSYS

Mylan

Hikma

Egalet

Opioids Drug Segment by Type

Oxycodone

Hydromorphone

Codeine

Fentanyl

Opioids Drug Segment by Application

Pain Relief

Anesthesia

Others

Opioids Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioids Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioids Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioids Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Opioids Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Opioids Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Opioids Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Opioids Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Opioids Drug Industry Trends Table 2. Opioids Drug Industry Drivers Table 3. Opioids Drug Industry Opportunities and Challenges Table 4. Opioids Drug Industry Restraints Table 5. Global Opioids Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Opioids Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Opioids Drug Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Opioids Drug Sales Market Share by Manufacturers Table 9. Global Opioids Drug Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Opioids Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Opioids Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Opioids Drug Manufacturers, Product Type & Application Table 13. Global Opioids Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Opioids Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oxycodone Table 17. Major Manufacturers of Hydromorphone Table 18. Major Manufacturers of Codeine Table 19. Major Manufacturers of Fentanyl Table 20. Global Opioids Drug Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 21. Global Opioids Drug Sales by Type (2021-2026) & (M Units) Table 22. Global Opioids Drug Sales by Type (2027-2032) & (M Units) Table 23. Global Opioids Drug Sales Market Share by Type (2021-2026) Table 24. Global Opioids Drug Sales Market Share by Type (2027-2032) Table 25. Global Opioids Drug Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 26. Global Opioids Drug Revenue by Type (2021-2026) & (M Units) Table 27. Global Opioids Drug Revenue by Type (2027-2032) & (M Units) Table 28. Global Opioids Drug Revenue Market Share by Type (2021-2026) Table 29. Global Opioids Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pain Relief Table 31. Major Manufacturers of Anesthesia Table 32. Major Manufacturers of Others Table 33. Global Opioids Drug Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 34. Global Opioids Drug Sales by Application (2021-2026) & (M Units) Table 35. Global Opioids Drug Sales by Application (2027-2032) & (M Units) Table 36. Global Opioids Drug Sales Market Share by Application (2021-2026) Table 37. Global Opioids Drug Sales Market Share by Application (2027-2032) Table 38. Global Opioids Drug Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 39. Global Opioids Drug Revenue by Application (2021-2026) & (M Units) Table 40. Global Opioids Drug Revenue by Application (2027-2032) & (M Units) Table 41. Global Opioids Drug Revenue Market Share by Application (2021-2026) Table 42. Global Opioids Drug Revenue Market Share by Application (2027-2032) Table 43. Global Opioids Drug Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 44. Global Opioids Drug Sales by Region (2021-2026) & (M Units) Table 45. Global Opioids Drug Sales Market Share by Region (2021-2026) Table 46. Global Opioids Drug Sales Forecasted by Region (2027-2032) & (M Units) Table 47. Global Opioids Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Opioids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 49. North America Opioids Drug Sales by Country (2021-2026) & (M Units) Table 50. North America Opioids Drug Sales by Country (2027-2032) & (M Units) Table 51. Europe Opioids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 52. Europe Opioids Drug Sales by Country (2021-2026) & (M Units) Table 53. Europe Opioids Drug Sales by Country (2027-2032) & (M Units) Table 54. Asia Pacific Opioids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 55. Asia Pacific Opioids Drug Sales by Country (2021-2026) & (M Units) Table 56. Asia Pacific Opioids Drug Sales by Country (2027-2032) & (M Units) Table 57. South America, Middle East and Africa Opioids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 58. South America, Middle East and Africa Opioids Drug Sales by Country (2021-2026) & (M Units) Table 59. South America, Middle East and Africa Opioids Drug Sales by Country (2027-2032) & (M Units) Table 60. Global Opioids Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Opioids Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Opioids Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Opioids Drug Revenue Market Share by Region (2021-2026) Table 64. Global Opioids Drug Revenue Market Share by Region (2027-2032) Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva Opioids Drug Product Portfolio Table 69. Teva Recent Development Table 70. Purdue Pharma Company Information Table 71. Purdue Pharma Business Overview Table 72. Purdue Pharma Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Purdue Pharma Opioids Drug Product Portfolio Table 74. Purdue Pharma Recent Development Table 75. Mallinckrodt Company Information Table 76. Mallinckrodt Business Overview Table 77. Mallinckrodt Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Mallinckrodt Opioids Drug Product Portfolio Table 79. Mallinckrodt Recent Development Table 80. Amneal Pharma Company Information Table 81. Amneal Pharma Business Overview Table 82. Amneal Pharma Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Amneal Pharma Opioids Drug Product Portfolio Table 84. Amneal Pharma Recent Development Table 85. Collegium Company Information Table 86. Collegium Business Overview Table 87. Collegium Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Collegium Opioids Drug Product Portfolio Table 89. Collegium Recent Development Table 90. J&J Company Information Table 91. J&J Business Overview Table 92. J&J Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. J&J Opioids Drug Product Portfolio Table 94. J&J Recent Development Table 95. Endo Company Information Table 96. Endo Business Overview Table 97. Endo Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Endo Opioids Drug Product Portfolio Table 99. Endo Recent Development Table 100. Pfizer Company Information Table 101. Pfizer Business Overview Table 102. Pfizer Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Pfizer Opioids Drug Product Portfolio Table 104. Pfizer Recent Development Table 105. INSYS Company Information Table 106. INSYS Business Overview Table 107. INSYS Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. INSYS Opioids Drug Product Portfolio Table 109. INSYS Recent Development Table 110. Mylan Company Information Table 111. Mylan Business Overview Table 112. Mylan Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Mylan Opioids Drug Product Portfolio Table 114. Mylan Recent Development Table 115. Hikma Company Information Table 116. Hikma Business Overview Table 117. Hikma Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Hikma Opioids Drug Product Portfolio Table 119. Hikma Recent Development Table 120. Egalet Company Information Table 121. Egalet Business Overview Table 122. Egalet Opioids Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Egalet Opioids Drug Product Portfolio Table 124. Egalet Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Opioids Drug Distributors List Table 128. Opioids Drug Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Opioids Drug Product Image Figure 2. Global Opioids Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioids Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Opioids Drug Sales (2021-2032) & (M Units) Figure 5. Global Opioids Drug Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Opioids Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oxycodone Image Figure 9. Hydromorphone Image Figure 10. Codeine Image Figure 11. Fentanyl Image Figure 12. Global Opioids Drug Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 13. Global Opioids Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Opioids Drug Sales Market Share by Type (2021-2032) Figure 15. Global Opioids Drug Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 16. Global Opioids Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Opioids Drug Revenue Market Share by Type (2021-2032) Figure 18. Pain Relief Image Figure 19. Anesthesia Image Figure 20. Others Image Figure 21. Global Opioids Drug Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 22. Global Opioids Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Opioids Drug Sales Market Share by Application (2021-2032) Figure 24. Global Opioids Drug Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 25. Global Opioids Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Opioids Drug Revenue Market Share by Application (2021-2032) Figure 27. North America Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 28. North America Opioids Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Canada Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Mexico Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 32. Europe Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 33. Europe Opioids Drug Sales Market Share by Country (2021-2032) Figure 34. Germany Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 35. France Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 36. U.K. Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Italy Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Netherlands Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 39. Asia Pacific Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Asia Pacific Opioids Drug Sales Market Share by Country (2021-2032) Figure 41. China Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Japan Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 43. South Korea Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Southeast Asia Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 45. India Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 46. Australia Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 47. South America, Middle East and Africa Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South America, Middle East and Africa Opioids Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 50. South Africa Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 51. Saudi Arabia Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 52. Turkey Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Argentina Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 54. UAE Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Egypt Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Chile Opioids Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 57. Global Opioids Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Opioids Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Opioids Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America Opioids Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Opioids Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe Opioids Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Opioids Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Opioids Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Opioids Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Opioids Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Opioids Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Opioids Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oxycodone
  • Hydromorphone
  • Codeine
  • Fentanyl
Applications
  • Pain Relief
  • Anesthesia
  • Others
Companies covered
  • Teva
  • Purdue Pharma
  • Mallinckrodt
  • Amneal Pharma
  • Collegium
  • J&J
  • Endo
  • Pfizer
  • INSYS
  • Mylan
  • Hikma
  • Egalet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Opioids Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Opioids Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Opioids Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Opioids Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Opioids Drug Market Dynamics
  1. 2.1 Opioids Drug Industry Trends
  2. 2.2 Opioids Drug Industry Drivers
  3. 2.3 Opioids Drug Industry Opportunities and Challenges
  4. 2.4 Opioids Drug Industry Restraints
3 Opioids Drug Market by Manufacturers
  1. 3.1 Global Opioids Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Opioids Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Opioids Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Opioids Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Opioids Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Opioids Drug Manufacturers, Product Type & Application
  7. 3.7 Global Opioids Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Opioids Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Opioids Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Opioids Drug Tier 1, Tier 2, and Tier 3
4 Opioids Drug Market by Type
  1. 4.1 Opioids Drug Type Introduction
  2. 4.1.1 Oxycodone
  3. 4.1.2 Hydromorphone
  4. 4.1.3 Codeine
  5. 4.1.4 Fentanyl
  6. 4.2 Global Opioids Drug Sales by Type
  7. 4.2.1 Global Opioids Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Opioids Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Opioids Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Opioids Drug Revenue by Type
  11. 4.3.1 Global Opioids Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Opioids Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Opioids Drug Revenue Market Share by Type (2021-2032)
5 Opioids Drug Market by Application
  1. 5.1 Opioids Drug Application Introduction
  2. 5.1.1 Pain Relief
  3. 5.1.2 Anesthesia
  4. 5.1.3 Others
  5. 5.2 Global Opioids Drug Sales by Application
  6. 5.2.1 Global Opioids Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Opioids Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Opioids Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Opioids Drug Revenue by Application
  10. 5.3.1 Global Opioids Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Opioids Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Opioids Drug Revenue Market Share by Application (2021-2032)
6 Global Opioids Drug Sales by Region
  1. 6.1 Global Opioids Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Opioids Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Opioids Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Opioids Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Opioids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Opioids Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Opioids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Opioids Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Opioids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Opioids Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Opioids Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Opioids Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Opioids Drug Revenue by Region
  1. 7.1 Global Opioids Drug Revenue by Region
  2. 7.1.1 Global Opioids Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Opioids Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Opioids Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Opioids Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Opioids Drug Revenue (2021-2032)
  8. 7.2.2 North America Opioids Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Opioids Drug Revenue (2021-2032)
  11. 7.3.2 Europe Opioids Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Opioids Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Opioids Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Opioids Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Opioids Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Opioids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Opioids Drug Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Purdue Pharma
  8. 8.2.1 Purdue Pharma Company Information
  9. 8.2.2 Purdue Pharma Business Overview
  10. 8.2.3 Purdue Pharma Opioids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Purdue Pharma Opioids Drug Product Portfolio
  12. 8.2.5 Purdue Pharma Recent Developments
  13. 8.3 Mallinckrodt
  14. 8.3.1 Mallinckrodt Company Information
  15. 8.3.2 Mallinckrodt Business Overview
  16. 8.3.3 Mallinckrodt Opioids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mallinckrodt Opioids Drug Product Portfolio
  18. 8.3.5 Mallinckrodt Recent Developments
  19. 8.4 Amneal Pharma
  20. 8.4.1 Amneal Pharma Company Information
  21. 8.4.2 Amneal Pharma Business Overview
  22. 8.4.3 Amneal Pharma Opioids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Amneal Pharma Opioids Drug Product Portfolio
  24. 8.4.5 Amneal Pharma Recent Developments
  25. 8.5 Collegium
  26. 8.5.1 Collegium Company Information
  27. 8.5.2 Collegium Business Overview
  28. 8.5.3 Collegium Opioids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Collegium Opioids Drug Product Portfolio
  30. 8.5.5 Collegium Recent Developments
  31. 8.6 J&J
  32. 8.6.1 J&J Company Information
  33. 8.6.2 J&J Business Overview
  34. 8.6.3 J&J Opioids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 J&J Opioids Drug Product Portfolio
  36. 8.6.5 J&J Recent Developments
  37. 8.7 Endo
  38. 8.7.1 Endo Company Information
  39. 8.7.2 Endo Business Overview
  40. 8.7.3 Endo Opioids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Endo Opioids Drug Product Portfolio
  42. 8.7.5 Endo Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Opioids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Opioids Drug Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 INSYS
  50. 8.9.1 INSYS Company Information
  51. 8.9.2 INSYS Business Overview
  52. 8.9.3 INSYS Opioids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 INSYS Opioids Drug Product Portfolio
  54. 8.9.5 INSYS Recent Developments
  55. 8.10 Mylan
  56. 8.10.1 Mylan Company Information
  57. 8.10.2 Mylan Business Overview
  58. 8.10.3 Mylan Opioids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mylan Opioids Drug Product Portfolio
  60. 8.10.5 Mylan Recent Developments
  61. 8.11 Hikma
  62. 8.11.1 Hikma Company Information
  63. 8.11.2 Hikma Business Overview
  64. 8.11.3 Hikma Opioids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hikma Opioids Drug Product Portfolio
  66. 8.11.5 Hikma Recent Developments
  67. 8.12 Egalet
  68. 8.12.1 Egalet Company Information
  69. 8.12.2 Egalet Business Overview
  70. 8.12.3 Egalet Opioids Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Egalet Opioids Drug Product Portfolio
  72. 8.12.5 Egalet Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Opioids Drug Value Chain Analysis
  2. 9.1.1 Opioids Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Opioids Drug Production Mode & Process
  6. 9.2 Opioids Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Opioids Drug Distributors
  9. 9.2.3 Opioids Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst